跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
RIAMET artemether/lumefantrine 20 mg/120 mg tablet blister pack
Approved
STANDARD
RIAMET artemether/lumefantrine 20 mg/120 mg tablet blister pack
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c7fb83c66b4afd71
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c7fb83c66b4afd71
Product Name
RIAMET artemether/lumefantrine 20 mg/120 mg tablet blister pack
Artg Id
90011
Artg Name
RIAMET artemether/lumefantrine 20 mg/120 mg tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2002-07-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/2392333b71f53cb823f25466143c41f1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c2859243cfd6ed74fc8b6ce249016a84.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c7fb83c66b4afd71
Type
Standard
Back to TGA Approvals
RIAMET artemether/lumefantrine 20 mg/120 mg tablet blister pack - TGA Drug Approval Details
